Frontiers in Immunology (Sep 2024)
Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
- Shi Zou,
- Shi Zou,
- Wei Guo,
- Wei Guo,
- Songjie Wu,
- Songjie Wu,
- Fangzhao Ming,
- Yuting Tan,
- Yuting Tan,
- Mengmeng Wu,
- Mengmeng Wu,
- Weiming Tang,
- Weiming Tang,
- Ke Liang,
- Ke Liang,
- Ke Liang,
- Ke Liang
Affiliations
- Shi Zou
- Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China
- Shi Zou
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
- Wei Guo
- Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China
- Wei Guo
- Department of Pathology, School of Basic Medical Sciences, Wuhan University, Wuhan, China
- Songjie Wu
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
- Songjie Wu
- Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China
- Fangzhao Ming
- Wuchang District Center for Disease Control and Prevention, Wuhan, China
- Yuting Tan
- Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China
- Yuting Tan
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
- Mengmeng Wu
- Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China
- Mengmeng Wu
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
- Weiming Tang
- Guangdong Second Provincial General Hospital, Guangdong, China
- Weiming Tang
- The University of North Carolina at Chapel Hill Project-China, Guangzhou, China
- Ke Liang
- Department of Infectious Diseases, Zhongyang Hospital of Wuhan University, Wuhan, China
- Ke Liang
- Wuhan Research Center for Infectious Diseases and Cancer, Chinese Academy of Medical Sciences, Wuhan, China
- Ke Liang
- Department of Nosocomial Infection Management, Zhongnan Hospital of Wuhan University, Wuhan, China
- Ke Liang
- Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1494940
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
- neutralizing antibodies
- inactivated COVID-19 vaccine
- people living with HIV (PLWH)
- seroconversion
- longitudinal humoral response